Osrodek Badan Klinicznych Bd Research Sp. z o.o.
- Address
- Ul. Gen. Wladyslawa Andersa 3, 14-200 Iława, Poland
Osrodek Badan Klinicznych BD Research Sp. z o.o.
BD Research is a clinical research center with extensive experience in conducting Phase II and Phase III trials across multiple therapeutic areas. The facility specializes in gastroenterology, dermatology, and hematology, demonstrating particular expertise in inflammatory and immune-mediated conditions requiring complex patient management and careful monitoring protocols.
- Inflammatory Bowel Disease research, including Crohn's disease and ulcerative colitis trials with novel biologic therapies and oral mesalazine formulations
- Dermatological conditions focusing on moderate-to-severe atopic dermatitis with innovative immunotherapy approaches
- Emergency hematology studies evaluating prothrombin complex concentrates for reversal of anticoagulation in acute bleeding scenarios
The center demonstrates capabilities in managing both chronic inflammatory conditions and acute emergency interventions. Their portfolio includes non-inferiority trials, dose-ranging studies, and efficacy assessments using validated clinical scoring systems such as the Modified Mayo Score and EASI. The facility's experience with biologic therapies, oral formulations, and hemostatic agents reflects a comprehensive approach to clinical investigation across diverse patient populations requiring specialized medical care.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 5 of 8 therapeutic areas and 14 of 16 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 3 by active trials.
- 1F. Hoffmann-La Roche AG1active
lock +2 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1F. Hoffmann-La Roche AG2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Osrodek Badan Klinicznych Bd Research Sp. z o.o.
lock Showing 1 of 8 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 2 Randomized, Placebo-controlled, Double-blind, Dose-ranging Study to Evaluate the Efficacy, Safety, and Tolerability of AMG 133 in Adult Subjects With Overweight or Obesity, With or Without Type 2 Diabetes Mellitus. | Amgen Inc. | Phase II | Not Recruiting | Mar 2023 | Oct 2025 |
IMP list
lock Showing 1 of 16 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Ro7790121 | 2 | Unknown | 2025-01-09 | 2025-04-16 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.